OB/GYN Clinical Alert
RSSArticles
-
Better Methods for Emergency Contraception
A single dose of 1.5-mg levonorgestrel and a single low dose of 10-mg mifepristone are effective methods for emergency contraception. -
Management of Invasive Carcinoma of the Uterine Cervix Associated with Pregnancy: Outcome in Intentional Delay in Treatment
Delay in treatment to allow for fetal maturity is safe in patients with early stage I cervical carcinoma associated with pregnancy. -
Walking and Leisure-Time Activity and Risk of Hip Fracture in Postmenopausal Women
Moderate levels of activity, including walking, are associated with substantially lower risks of hip fracture in postmenopausal women. -
Clinical Briefs in Primary Care Supplement
-
Special Feature: Total or Subtotal Hysterectomy: Which is Superior?
As the new kid on the OB/GYN Clinical Alert block, and as the generalist among the editors, I intend to focus on topics that come up commonly in my own practice of obstetrics and gynecology. The beauty of having this format is that cutting edge science can be presented, but also sacred cows can be challenged. -
Cesarean Section for all Breeches? Is the Final Answer In?
In December, a group from Austria published a report evaluating outcomes of infants presenting at term with breeches whose mothers were scheduled to have either an elective cesarean section or a planned vaginal birth. -
Pharmacology Watch: Vardenafil Will Compete for Share of ED Market
The FDA has approved vardenafil (LevitraBayer and GlaxoSmithKline) for the treatment of erectile dysfunction in men. Vardenafil joins sildenafil (Viagra) as the only 2 drugs approved for this indication in this country. -
Clinical Briefs in Primary Care Supplement
-
Seasonale: A Revolutionary Contraceptive
-
Death by a Thousand Indignities: The Saga of HRT
This week there were 2 articles in the New England Journal of Medicine that explored the link between postmenopausal hormone use and heart disease. The first article was the final analysis of the Prempro® arm of the WHI.